Envy Medical, Inc., a leader in professional skin care products and services, has secured new growth capital from HCP & Company, a middle-market private equity firm headquartered in Chicago. The new funding will support sales and marketing initiatives, while also allowing the company to accelerate the development and introduction of exciting new skin care offerings designed to meet the growing demand for healthier skin tone, texture and function, the company contends.
“This is the first time in Envy’s history that we have taken on outside growth capital, and we did so with unanimous board and shareholder support” said Chief Executive Officer Curtis A. Cluff “That support is due in large part to HCP’s business acumen and an understanding that they bring significant experience to the table as Envy accelerates growth towards becoming a major global player in the specialized skin care market.”
HCP has developed its expertise in the personal care and beauty segments, working with high growth/large market potential companies that require capital to accelerate growth. Their investment is targeted primarily for that purpose.
“Looking across the professional skincare and physician dispensed markets, we recognize how very well positioned Envy is to be a dominant player in its market,” commented Carlos Signoret, HCP partner and co-founder.